Nightingale’s share transfer to the main list of the stock exchange is progressing

The Financial Supervisory Authority was approved by a medical technology company Nightingalen Listing brochure on Monday.

The company’s B share is moving from the First North Growth List to the main list of the Helsinki Stock Exchange. It is expected to start on the main list of trading on March 19, 2025, provided Nasdaq Helsinki approves the company’s application for listing. The company submitted the application last Viko.

Earlier on Monday, the company announced that the listing projects would also proceed in the United States.

Nightingale In November, he said that it will explore the chances of listing their shares in the US OTC market.

On Monday, the company announced that it had requested an request to the OTC Markets on the OTCQX International marketplace, with the first trading day at the earliest on March 19, 2025 and no later than 24 March 2025.